Cargando…
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
INTRODUCTION: Chronic breathlessness is highly prevalent and distressing to patients and families. No medication is registered for its symptomatic reduction. The strongest evidence is for regular, low-dose, extended- release (ER) oral morphine. A recent large phase III study suggests the subgroup mo...
Autores principales: | Currow, David, Watts, Gareth John, Johnson, Miriam, McDonald, Christine F, Miners, John O, Somogyi, Andrew A, Denehy, Linda, McCaffrey, Nicola, Eckert, Danny J, McCloud, Philip, Louw, Sandra, Lam, Lawrence, Greene, Aine, Fazekas, Belinda, Clark, Katherine C, Fong, Kwun, Agar, Meera R, Joshi, Rohit, Kilbreath, Sharon, Ferreira, Diana, Ekström, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726102/ https://www.ncbi.nlm.nih.gov/pubmed/28716797 http://dx.doi.org/10.1136/bmjopen-2017-018100 |
Ejemplares similares
-
P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022) -
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
por: Date, Kathryn, et al.
Publicado: (2023) -
Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study
por: Ferreira, Diana, et al.
Publicado: (2022) -
Regular, low-dose methadone for reducing breathlessness in people experiencing or at risk of neurotoxic effects from morphine: A single-center case series
por: Sobanski, Piotr Z., et al.
Publicado: (2022) -
Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness
por: Watts, Gareth J, et al.
Publicado: (2016)